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Spinal cord injury is one of the most devastating neurologic conditions that mostly affects young, and
otherwise healthy, patients. Following the primary phase of injury, deleterious secondary inﬂammation
and vascular disruption lead to a more sustained and permanent damage. Over the years, various animal
models of spinal cord injury have been developed to help understand the mechanism and the patho-
physiology of injury, and to develop reliable treatment strategies. These animal models, especially for the
mouse, have also become the target of stem cell therapy, which aims to replace the lost cellular element
at the site of injury. In this review, we will discuss the different types of mouse models of spinal cord
injury, and elaborate on the therapeutic use of stem cells transplantation.
© 2015 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Spinal cord injury (SCI) is a devastating condition that may
result in a permanent neurological damage ranging from minor
deﬁcit, to hemiplegia, quadriplegia, and death. Despite the exten-
sive and rapid advancement in medicine, there is still no effective
therapy. Over the last two decades, stem cell therapy has attracted
great attention for treating SCI by replacing the lost cellular and
supporting elements [20,21]. Different types of stem cells at various
stages of maturation have been used. Nevertheless, the safety and
efﬁcacy of this method has not been well established in humans to
date and further animal studies are needed. The mouse model of
SCI has been greatly utilized for spinal cord research purpose. This
animal-based research can give insight into human research,
despite the differences between the two types of cells.
Herein, we will discuss the different types of mouse models of
SCI, with emphasis to the prominent studies performed on these
models.2. Chronological development of animal models of spinal
cord injury
The ﬁrst experimental generation of SCI in animal models was
performed by Schmaus [26], who studied the effect of concussion
on rabbit spinal cord. The injury was induced by tying a wooden
board on a rabbit's back and performing a blow trauma to the
board. Thereafter, various mechanisms for inducing SCI in different
animal models were innovated [34].
Allen [2] developed a weight drop method to induce a spinal
cord contusion model in canines. The injury was induced by
dropping a weight from a measured height through a perpendic-
ular tube on the exposed spinal cord with intact dura mater. Ayer
[4] produced compression injury of spinal cord by injecting parafﬁn
into the epidural space of feline spinal cord. McVeigh [19] produced
compression injury in dogs via the ﬁngertip. Thompson [32] pro-
duced crush injury in cats' spinal cord via a ﬁngertip and scalpel
handle. Ferraro [10] induced spinal cord concussion in rabbits by
applying a blow to the back with an iron rod. Craig [7] produced
compression injury in cat spinal cords by inserting pieces of bone
wax into the intradural space around the spinal cord.
Tarlov et al. [31] developed a hydraulic compression device to
produce both acute and chronic compression injuries in dogs.
Rubber hydraulic balloons were inserted into the epidural space toproduce quantitative degenerative lesions. Gelfan and Tarlov [12]
postulated that the conduction block caused by canine spinal
cord compression was reversible and was directly related to me-
chanical deformation rather than anoxia. Coe et al. [6] induced
cervical spinal cord ﬂexion compression in a rhesus monkey, by
rigid ﬁxation of the head with body acceleration. Harvey and
Srebnik [13] induced spinal cord crush injury in rats, using thumb
forceps. Ducker and Hamit [9] developed a beagle model of spinal
cord contusion, using the weight drop technique. Kelly et al. [15]
induced spinal cord contusion in dogs, and reported signiﬁcant
recovery following treatment with hypothermia and hyperbaric
oxygen. Yeo and Payne [36] and Yeo et al. [35] developed a
contusion model of SCI in sheep by weight drop. Sheep spinal cord
more closely resembles the spinal cord of humans compared to
other animal models, especially in terms of size. DeGirolami and
Zivin [8] developed a spinal cord ischemia model in rabbits by
placing a polyethylene catheter around the aorta distal to the renal
artery. Sholomenko and Steeves [29] induced a variety of hemi-
section SCI in Canadian geese and Peking ducks. Wrathall et al. [33],
have introduced modiﬁcations to the original weight drop method
of Allen [2] and used a device in which a weight is dropped along a
vertical rod on an impounder applied to the spinal cord. Their
technique has been one of the most popular techniques of inducing
SCI due to being simple and cheap. Blight [5] developed a guinea
pig model of spinal cord compression, by using a modiﬁed pair of
forceps.3. Mouse models of spinal cord injury
Mouse models of SCI offer the advantage of being cost effective
in terms of buying and maintaining the samples [17]. Moreover,
mice are exposed to a diversity of natural mutations as well as
genetically engineered ones, which offer a wider scope of possi-
bilities for research.3.1. Graded contusive model using weight drop method
Kuhn and Wrathall [17] developed a mouse model of graded
contusive SCI using a weight drop method. Contusive models of SCI
are most appropriate in terms of mimicking human injuries, which
are mostly caused by non-penetrating blunt trauma (e.g., fall,
vertebral dislocation, and burst fracture). Their method was
modiﬁed from the impounder weight drop technique used by
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processes around the areawhere the impounder will be applied are
clamped with McPherson forceps to achieve spinal column stabi-
lization. A nylon impounder with a tip diameter of 1.5 mm is
applied against the spinal cord. The nylon impounder is loosely
ﬁtted over the end of a brass rod that is inserted through the
weight. The brass rod itself is attached to a stereotactic frame for
precise positioning. Fine adjustment of surgical planes can be
performed with a microscope mounted overhead and attached to
the rod that supports the impounder. The weight used in this study
for contusive injury ranged from 1 gm  2.5 cm to 3 gm  5 cm.
3.2. Graded contusive model using pneumatic impact device
Seki et al. [28] developed a contusive SCI model using a pneu-
matic impact device, which was modiﬁed from the weight drop
device. The advantage of pneumatic compression device over the
weight drop method is the precise control of impact and biome-
chanical monitoring of variations associated with impact injury.
Rate, depth, and duration of impact are controlled precisely, and the
bouncing effect on dura, which is a major drawback in the weight
drop method, is eliminated with the pneumatic impact model.
The pneumatic impact device consists of a 1.5 mm bore, double
acting, pneumatic cylinder with a 5 cm stroke. The cylinder is
mounted vertically on a cross bar that can be adjusted along the
vertical axis. The impactor is mounted on the lower end of the rod
and is applied against the spinal cord. The transducer core of a
linear variable differential transformer is attached to the upper end
of the rod. A time displacement curve is used tomeasure the impact
velocity. Between 1 and 4.4 m/s range of impact velocity can be
generated by applying a controlled gas pressure to the impactor.
Controlled gas pressures of 12, 20, and 45 psi when applied to the
impactor can generate velocities of 1, 2, and 3 m/s, respectively. The
SCI produced is directly related to the impact velocity, total time of
impact, and depth.
3.3. Spinal cord ischemic injury model
Spinal cord ischemia is a devastating complication of aortic
aneurysm repair, aortic rupture, and dissection of the aorta, and
may lead to acute or delayed paralysis. To study the histopathologic
changes, various animal models of spinal cord ischemia have been
developed. The most popular is the rabbit model developed by
DeGirolami and Zivin [8]. In this model, the infrarenal segment of
the aorta was occluded, leading to paraplegia. The major drawback
of this model is its difference from spinal cord ischemia mechanism
in humans. In humans, infrarenal occlusion of the aorta does not
cause paraplegia because spinal cord at the thoracolumbar level is
supplied by the artery of Adamkiewicz, which arises from left
posterior intercostal arteries, mostly between T8 and L1.
Lang-Lazdunski et al. [18] developed the ﬁrst mouse model of
spinal cord ischemia. Spinal cord ischemia in mice mimics that of
humans due to the similarity in vasculature, with one anterior and
two posterior spinal arteries, and heterosegmental radicular
arteries.
In their model, the left internal mammary artery and aortic arch
between the left subclavian and common carotid arteries were
occluded with a clip. Within 15 s of occlusion, another clip was
applied at the origin of the left subclavian artery. Occlusion was
applied for 9 min (Group A) and 11 min (Group B), after which clips
were removed. Motor function was assessed at 0, 1, 3, 6, and 24 h
after removal of occlusion clips. Both study groups became acutely
paraplegic. In Group A, motor function recovered within 24 h of
occlusion, while in group B, 80% showed complete paralysis.
Histologically, spinal cord sections at T5 to T7 showed nochanges, while L1 to L5 showed changes in all the sections. In group
A, the dorsal horn was maximally affected. The intermediate gray
matter was also affected. The ventral horns were minimally
affected. Less than 10% of motor neurons had eosinophillic cyto-
plasm. In group B, dorsal horns and intermediate gray matter had
comparatively more red neurons, and more than 50% of motor
neurons were eosinophillic. Only group B had parenchymal edema.
With the ventral surgical approach described by Lang-Lazdunski
et al. [18], it was difﬁcult to isolate aortic arch and left subclavian
artery from the adjacent tissue, to achieve complete occlusion for
the application of the clip. Furthermore, with this approach, it was
difﬁcult to separate the vagus nerve from the left subclavian artery
without damaging it, which has resulted in a high mortality rate. To
overcome this drawback, Awad et al. [3] used a lateral thoracotomy
approach, which facilitated the separation of vessels and nerves,
and allowed for easier access to the descending aorta for complete
occlusion.
In comparing their method to the ventral surgical approach of
Lang-Lazdunski et al. [18], the lateral approach by Awad et al. [3]
was associated with a mean survival of 68 h after clip application
for 3e11 min, compared to 39 h following the ventral approach.
With lower body temperature, there was a signiﬁcant increase in
mean survival, reaching up to 63 days at 33 C and clip application
for 7.5 min.
3.4. Photochemical graded ischemic injury model
Gaviria et al. [11] developed a mouse model of photochemical
graded spinal cord ischemic injury. After the exposure of laminae
and spinous processes of T8-T10, the spinal cord was exposed to
Xenon lamp irradiation beam (560 nm wavelength), focused
through ﬁber optics. Animals were sacriﬁced at day 1 or 7 post
injury, andwere divided into ﬁve groups according to the size of the
ﬁber optics and the duration of exposure. 1- Animals irradiated for
5 min with 5 mm ﬁber optic exposure showed loss of 30% of mean
gross motor function, and impairment of 30% of bladder and mean
reﬂective functions. The nociceptive response was mild to moder-
ately increased. 2- Animals irradiated for 6 min with 5 mm ﬁber
optic exposure showed 50e75% loss of mean gross and ﬁne motor
function, 80e90% impairment of bladder function, and 70e80%
impairment of mean reﬂective function. Nociceptive response
increased to 40%. 3- Animals irradiated for 6 min with 3 mm irra-
diation showed similar outcome as 5 min with 5 mm ﬁber optic
irradiation group animals. There was mild to moderate impairment
of functions. 4- Animals irradiated for 7 min with 3 mm irradiation
showed loss of 50e60% of mean grossmotor function, 80% decrease
in mean ﬁne motor function, and impairment of 80% of bladder
function, 40e70% of mean reﬂective functions, and 80% of mean
proprioceptive function. The nociceptive response was increased to
20e30%. 5- Animals irradiated for 8 min with 3 mm irradiation
showed loss of 70e90% of mean grossmotor function, 90% decrease
in mean ﬁne motor function, and impairment of 100% of mean
bladder function, 80e100% of mean reﬂective function, and 100% of
mean proprioceptive function. The nociceptive response was
increased to 10e50%. In animals that were moderately-to-severely
injured, that is, irradiated for 5e8min, themost commonly affected
anatomic regionwas the entire dorsal funiculus. In severely injured
animals, almost the entire spinal section was affected, including
dorsal horns, central canal, lateral funiculus, ventral horns, and
ventral white maters.
Histologically, there was absence of cavitation and necrosis at
the photochemical lesion site. Neural tissue was replaced by
cellular and extracellular matrix conﬁrmed by Luxol fast blue and
Nissl-stained glial ﬁbrillary acidic protein (GFAP) labeling. During
the early phase post injury, the site was edematous with neutrophil
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lesion site was inﬁltrated by macrophages, ﬁbroblasts, endothelial
cells, and polymorphoneuclear cells.
3.5. Transection model
Seitz et al. [27] developed a spinal cord transection mouse
model. The aim of this model was to minimize the scar formation
after the injury, which is a major block for the regeneration capa-
bility of the nervous system. In their study, two types of surgeries
were performed. In the ﬁrst group, the dura was left open, and in
the second group, the dura was left intact. In the “cut dura” group,
the spinous processes of T8-10 were exposed by a 1.3 cm dorsal
median incision. A forceps was used to hold the spinous process of
T8 or T9 and was lifted to open the intervertebral space. Complete
transection of the spinal cord was achieved using a micro scalpel.
The incisionwas performed bymoving the scalpel from right to left
and again from the left to right directions with the tip of the scalpel
moving over the osseous part of the spinal canal to ensure complete
transection.
In the ‘intact dura’ animals, the micro scalpel blade was modi-
ﬁed to a size of 0.4 mm high and 5 mm long. After a 0.5 mm lon-
gitudinal incision of the dura, complete transection of the spinal
cord was achieved by inserting the blade between the spinal cord
and dura towards the right side and cutting the complete circum-
ference of spinal cord. Complete transection was conﬁrmed by
sliding the blade against the osseous surface of the spinal canal.
The Basso, Beattie, and Bresnahan (BBB) scale was used to assess
the motor function at 1, 4, 7, 14, and 21 days post surgery. Both
groups showed recovery within the ﬁrst 3 weeks. In the ‘intact
dura’ group, animals started moving their hindlimbs in two weeks,
and more than half of the animals showed improvement, and
scored 15e20 points on BBB scales within 3 weeks. To rule out
reﬂex automatism as the cause of improvement, two animals that
showed recovery were re-injured and showed no hindlimb move-
ment immediately and 2 weeks post re-injury. In the ‘cut dura’
group, therewas extensive ﬁbroblast inﬁltration and increase in the
gap between the cut ends of spinal cord. On the contrary, in the
‘intact dura’ group, scarring was prevented. The inﬁltration and
collagenwere less dense. Retrograde tracing was performed after 2
weeks of injury in 2 animals of the ‘cut dura’ group that scored 0 on
the BBB scale, and 2 animals from the ‘intact dura’ group that scored
15 on the BBB scale.
Two weeks after injury, 0.1 ml of 5-(and-6)-Tetramethylrhod-
amine in 5% solution of phosphate-buffered saline (PBS) was
injected under pressure using a 20 mm pulled glass micropipette on
both sides of gray matter of the lumbar enlargements. Each injec-
tion lasted for 5 min and the pipette was left for another ﬁve mi-
nutes before it waswithdrawn. Five days after the injection, animals
were perfused, and 15e20 mm frontal sections of cortex and
brainstem, and longitudinal section from the site of injection were
performed. Specimens with tracer leakage in subarachnoid space
and area above the injection site were excluded. In the ‘intact dura’
model, retrograde-labeled neurons were seen in considerable
numbers. The nucleus vestibularis lateralis, nucleus ruber, nucleus
raphe, and nucleus gigantocellularis alphawere labeled with tracer.
In the ‘cut dura’ group, one animal showed no labeled neurons and
the second animal showed minute labeling in nucleus gigan-
tocellularis and nucleus vestibularis lateralis. Few labeled neurons
in the hindlimb-corresponding cortex of the ‘intact dura’ group
were seen, in contrast to not-labeled neurons in the ‘cut dura’ group.
3.6. Graded forceps crush model
Plemel et al. [24] developed a spinal cord crush model usingforceps. The aim of this model was to produce varying degrees of
SCI using forceps with spacers, which help in controlling the force
of impact on the spinal cord. The width of the forceps blades was
adjusted to 0.5 mm. Spacers were placed between the blades, so
once the forceps closes, it creates a varying closure distance that
compresses the cord to the thickness of 0.25 mm, 0.4 mm, and
0.55 mm, graded as mild, moderate, and severe, respectively.
T6eT7 laminectomy was performed, and dura was kept intact. The
compressionwas maintained for the duration of 15 s. A sham group
was also included. After recovery, ﬁeld locomotion, foot print and
horizontal ladder paradigms were used to assess the hindlimb
motor functions. Post surgical day 2, 4, and 7 were used for open
ﬁeld assessment, which was performed on a weekly basis there-
after. Open ﬁeld locomotor assessment was performed using Basso
mouse scale (BMS), which was deemed to be more sensitive than
the BBB for mouse locomotion testing, with inter-rater reliability of
0.5.
On assessment, the mild injury group (0.55 mm) scored an
average of 8.6 ± 0.12 on BMS. This group showed only abnormal tail
position or instability of the trunk. The moderate injury group
(0.4 mm) scored an average of 7.6 ± 0.51 on BMS. The animals
achieved coordination between the forelimbs and hindlimbs,
plantar stepping, and parallel paw placements, but the animals
were unstable and rotated their paw while lifting it up. The group
with severe injury (0.25 mm injury) scored an average of 4.2 ± 0.57,
which signiﬁes that the animal performed occasional plantar
stepping.
Tissue analysis was performed by using immunoreactivity to
GFAP-speciﬁc antibody. In the mild injury group, GFAP tissue was
present in gray matter and lateral columns of the lesion. In the
moderate injury group, GFAP tissue was present throughout the
gray matter sparing only a rim of white matter in the spinal cord. In
the severe injury group, GFAP tissue was present throughout the
site of injury sparing only peripheral patches of GFAPþ tissue,
which showed enhanced astrocytic reaction.
Myelin basic protein (MBP)-immunoreactivity was used to
analyze the myelin disruption. The mild injury group showed
myelin degeneration in the lateral funiculus at the epicenter of the
crush injury. Myelinwas normal at 800 mm rostral and caudal to the
epicenter. The moderate injury group had central degeneration
with a spared white matter rim, the tissue caudal and rostral to the
lesion epicenter showed patchy degeneration. In the severe injury
group, myelinwas absent at the epicenter of crush injury. Thewhite
and gray matter was signiﬁcantly degenerated 1200 mm rostral and
caudal to the lesion.
To compare the cytoarchitecture of lesions among the groups,
laminin and ﬁbrin immune-staining was performed. Mild injury
group had less than 0.2 mm2. The lesion site was ﬁlled with
phagocytes, surrounded by laminin and ﬁbronectin immunoreac-
tive material. The moderate injury group had lamininþ cells that
bridged the spared rim of spinal cord tissue. The severe injury
group had laminin and ﬁbronectin staining occupying the entire
injured site.
4. Neural stem cells
4.1. Neural stem cells derived from embryonic stem cells
4.1.1. Introduction
Okada et al. [22] described the modiﬁed in vitro technique to
induce neural stem cells (NSC) using mouse embryonic stem cells
(ESC). Until that time, mid to late gestational or adult brains were
used to obtain the NSC, but the plasticity in these cells was limited.
The older protocols had to be changed according to the cell type,
and they also lacked the ability to evaluate the association between
A. Deep et al. / Translational Research in Anatomy 1 (2015) 2e106spatial and temporal identities using the same culture system.
These protocols were also vulnerable to contamination by non
neural cells and various undifferentiated cells. In the new protocol
there was no need to add leukemia inhibitory factor (LIF) to keep
the embryonic stem cells in an undifferentiated state, and the
ﬂoating culture technique allowed the formation of embryoid
bodies (EB).
4.1.2. Methods
In this study [22], standard ESCmediumwith 0.1% gelatin coated
tissue culture dishes were used to produce neurospheres from ESC
through EB formation. Noggin in a concentration range of 0e10 mg
and/or retinoic acid 0e2 106 Mwere added. Retinoic acid acts as
a neural inducer of ESC, and also as a caudalizing factor for hind-
brain and rostral spinal cord formation. Noggin has a special
property of inhibiting bone morphogenetic signaling and inducing
forebrain development.
4.1.3. Results
4.1.3.1. Generation of neural stem cells. In their previous experi-
ment [23], the authors found that noggin and retinoic acids in
concentration of 108 M induced Sox1þ and Nestinþ neural pro-
genitors. They also found that post mitotic bIII-Tubulinþ neurons
were induced by 106 M concentration of retinoic acid. In the
current experiment, they could produce 2.6 fold (1 mg/ml noggin)
and 4 fold (106M retinoic acid)more neurospheres. To conﬁrm the
origin of neurospheres from NSC and self renewal properties,
noggin or low retinoic acid neurospheres (low density culture
2.5  104 cells/ml) generated the secondary neurospheres when
deposited on 96 well plates, which proved their self renewal po-
tential. Basic ﬁbroblast growth factor (bFGF)-containing serum free
media with noggin and low retinoic acid was used to culture
dissociated EB for 7 days to form primary neurospheres. Primary
dissociated neurospheres were then cultured in bFGF and
epidermal growth factor (EGF)-containing media for 8e9 days to
form secondary and tertiary neurospheres. EB cultured for 4 days at
high concentration of retinoic acid (106 M) produced primary
neurospheres but no secondary neurospheres. Immunocytochem-
ical analysis for the markers of neurons (bIII-Tubulin), astrocytes
(GFAP), and oligodendrocytes (O4) showed that the majority of the
primary neurospheres composed of neurons only and a small
number of glial cells. The secondary and tertiary neurospheres
contained more glial cells and multipotent colonies, which were
consistent with in vivo development, where glial cell generation
follows neuronal generation.
Analysis was performed to evaluate clonal neurospheres for-
mation. Monomeric red ﬂuorescent protein (mRFP) or venous
expressing lentivirus were used to transduce dissociated EB. They
were plated in 1:1 ratio of 0.45e1 104 cell density and cultured in
a hormone mix media (MHM0) containing 0.8% methylcellulose,
and bFGF in a concentration of 20 ng/ml, for secondary neuro-
spheres formation.
4.1.3.2. Electrophysiological analysis. Electrophysiological analysis
via whole cell patch clamp was performed to test the functionality
of neurons. Noggin treated EB-derived neurospheres were allowed
to dissociate and differentiate for 10e14 days on Ploy-L-ornithine/
ﬁbronectin coated cover glasses before testing. Tests showed
transient inward (Naþ) and sustained outward currents (Delayed
rectiﬁer Kþ). The holding voltage was 60 mV and command
voltage ranged from 80 to 50 mV. Transient Naþ current showed
sensitivity to tetrodotoxin. Sustained positive current stimulus
resulted in repetitive action potential ﬁring in all the neurons that
were being tested. These tests showed that these neurons were
electrophysiologically intact.4.1.3.3. Markers analysis. Rostrocaudal characteristics of neural
stem cells were identiﬁed by using various concentrations of
noggin and retinoic acid. Forebrain and midbrain markers (Foxg1,
Otx1, Otx2, and Enl) and markers for hindbrain (Pax2, Gbx2, Hoxb1,
Hoxa2, and Hoxb4) were expressed by noggin and low-retinoic acid
neurospheres, respectively. High-retinoic acid neurospheres
expressed Pax2þ and Hoxb4þ markers for hindbrain and spinal
cord, but not Otx1þ markers for forebrain and midbrain. This
further proves that retinoic acid, in a concentration-dependent
manner, can drive the caudalization on NSC when added during
formation of EB. Noggin and low retinoic acid neurons were posi-
tive for choline acetyltransferase (ChAT), glutamic acid decarbox-
ylase (GAD67), GABA, tyrosine hydroxylase (TH) and serotonin (5-
HT). High-retinoic acid neurons expressed GAD67þ and ChATþ
but not 5-HT or TH. Dorsoventral identity of NSC was regulated by
the addition of sonic hedgehog (SHH), which determined the
dorsoventral axis from ventral notochord and ﬂoor plate. Wingless
(wnt3a) and basic membrane protein (BMP)-4 determined the axis
from dorsal roof plate. These secreted factors were added during
the formation of neurospheres. Basal forebrain marker Nkx2.1 was
expressed by noggin neurospheres treated with 300 nm of SHH,
and generated 69.2 ± 8.2% Nkx2.1þ ventral colonies. 50 ng/ml
concentrations of Wnt3a-treated neurospheres produced
84.0 ± 3.1% Pax6þ dorsal colonies. Midbrain marker (Gsh2 and
Dlx2) expression was unaffected with or without adding SHH or
Wnt3a secretory factors. Low-retinoic acid neurospheres (control)
normally expressed ventral identity and gave rise to 82.4 ± 5.9% of
Nkx6.1 ventral colonies and fewer, 25.7 ± 2.9% of Pax3þ, dorsal-
identity colonies. The addition of 300 nm SHH further increased
the Nkx6.1 ventral colonies to 96.7 ± 1.5%, and addition of Wnt3a in
a concentration of 50 ng/ml further increased the Pax3þ dorsal
colonies proportion to 51.4 ± 5.8%. High-retinoic acid neurospheres
(control) produced very small number of Nkx6.1 ventral colonies
and about 44.4 ± 11.7% of Pax3þ dorsal colonies. Addition of 300 nm
of SHH increased the Nkx6.1 ventral colonies to 61.2 ± 10.9%, and
addition of 50 ng/ml of Wnt3a increased the expression of Pax3þ
colonies to 65.5 ± 9.3%. To test the ability of forming synaptic
connections, low-retinoic acid neurospheres were generated from
ES, which were tagged genetically with green ﬂuorescent protein
(GFP). Neuromuscular contacts were expressed by GFP-labeled
neurons after labeling with rhodamine a-bungarotoxin.
4.2. Embryonic stem cell-derived neural stem cell transplantation
4.2.1. Preparation of neural stem cells
Kimura et al. [16] described a technique to transplant NSC
derived from ESC into the injured spinal cord of an adult mouse.
They also investigated the advantage of adding thyroxine (T4) to
the therapy. An adult female 129/Svj mouse model was used for the
experiment. EB3 ESC-derived G4-2 murine cell line was used for
transplantation. G4-2 cells express enhanced green ﬂuorescent
protein (EGFP) gene, which is under the control of CAG unit
expression. Gelatin coated dishes without feeder cells in DMEM
medium were used to maintain undifferentiated G4-2 ESC. The
culture media was also enriched with 10% fetal bovine serum (FBS),
10 mM Sodium pyruvate, and 0.1 mM of 2-mercaptoethanol, 10 nM
non-essential amino acids and 1400 U/ml of LIH. To eliminate un-
differentiated cells, media containing 10 mg/ml of blasticidin was
used to culture G4-2 cells. EB were formed from undifferentiated
ESC (stage 1) and cultured in hanging drops at a cell density of
500 cells per drop for 4 days without LIF (stage 2). EB adherence
was promoted by plating it on gelatin coated tissue culture surfaces
for 24 h. ESC medium was replaced by serum free insulin/trans-
ferring/selenium/ﬁbronectin media for 7 days to initiate Nestinþ
cell selection (stage 3). N2medium enrichedwith laminin (1 mg/ml)
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days (stage 4).
Graft cell characteristics were analyzed using immunocyto-
chemistry. Nestin, oligo 1, GFAP, and MAP2 expression was absent
in undifferentiated ESC. Nestin mRNA was expressed by cells in
stage 2, MAP2 in stage 3, and the oligo 1 mRNA in stage 4 of culture.
After stage 4, the cells were harvested and recultured in media
without bFGF, which resulted in early appearance of MAP2þ
(neurons) cells within few days along with O4þ (oligodendrocytes)
and GFAPþ (glial cells) cells. To prepare the cells for transplantation,
the Nestinþ cells, after stage 4, were trypsinized with 0.25% trypsin
for 5 min at 37 C, and dissociated cells were suspended in PBS.
4.2.2. Spinal cord injury model
SCI was created in 10e12-week-old adult female 129/Svj mice. A
T9-T10 laminectomy was performed. With the dura kept intact,
contusion injury was induced using a pneumatic direct impact
device consisting of a 1.0 mm bore pneumatic impactor and 5.0 cm
stroke capable pneumatic cylinder. 40 psi of impact pressure was
used to achieve an impact velocity of approximately 3000 m/s to
create a constant impact depth of 0.5 mm for a duration of 50 msec.
4.2.3. Transplantation
Mice were divided into three groups. Group I mice received no
treatment. Group II and III were transplanted with 2  104 graft
cells in 2 ml of PBS into the injured site, 10 days post SCI. Group III
mice were also transplanted with an intraperitoneal osmotic mini
pumpwhich contained 0.2 ml of T4 solution for continuous 14 days
injection. To prepare T4 solution, 5 mg of I-T4 was mixed in 0.1 N
NaOH (1 ml) and 0.15 ml of T4, NaOH solution was mixed in 100 ml
of normal saline to achieve ﬁnal concentration of 7.5 mg/ml. The
pump was re-implanted intraperitonially after 14 days to achieve
continuous 28 days infusion of T4. On the 28th day after the
transplantation, immunohistological analysis of the spinal cordwas
performed.
4.2.4. Behavioral assessment
Behavioral assessment was performed at day 1 and one week
after the injury and again 7, 14, 21, and 28 days after the trans-
plantation. Mice were trained and selected randomly for the
assessment. Three scoring parameters were used: (1) Motor score,
by testing coordinated motor function in an open ﬁeld with score
range from 0 to 6; (2) Platform hang, which assesses the ability of
mice to climb on the top of a platform with the help of hindlimbs
with forelimbs placed on the edge of the platformwith score ranges
from 0 to 4; and (3) Rope walk, to assess the ability to navigate a 15
inch long, ½ inch wide sisal rope suspended 1 foot above the
bedding, with the score range from 0 to 4 points. Signiﬁcant
improvement was shown by Group II and III on days 21 and 28.
There was no signiﬁcant difference between group II and III
throughout the 4 week assessment. Injection of thyroxine did not
show any advantage.
4.2.5. Histological analysis
On day 28, mice were euthanized and the spinal cord was ﬁxed
in 4% paraformaldehyde in PBS at 4 C for 24 h and then transferred
to 10% and 15% sucrose in PBS at 4 C for 4 h each, followed by 20%
sucrose in PBS at 4 C overnight. Specimens were cut in 10 mm slices
with cryostat and mounted on 3-aminopropyltriethoxysaline
coated slides. These slides were rinsed in PBS and incubated in
anti-GFP in 1:9000 dilution, anti-Tuj1 in 1:2000 dilution, anti-
Nestin (1:500), and anti-O4 (1:1000) with 0.1% triton (X-100)
overnight at 4 C. After overnight incubations, sections were rinsed
in PBS incubate for 60min inmedia containing Rhodamine (1:200),
a ﬂuorescent-labeled secondary antibody with 0.1% Triton X-100.These sections were again rinsed in PBS and mounted and cover
slipped for evaluation with laser confocal microscope. In Group I,
empty cavity was seenwith reactive astrocytosis and loss of volume
on dorsal aspect of spinal cord. In Group II, there was no cavity at
the transplanted site and astrogliosis was less prominent on the
edges. GFAPþ cells were present in the cavity. Among the GFAPþ
cells, Tuj1þ and O4þ cells were present suggesting that embryonic
cell-derived neural stem cells differentiated into neurons and oli-
godendrocytes. Few axons from the graft sprouted and few axons
were also seen penetrating the graft, but there was clear demar-
cation between the spinal cord and graft. There was no tumor
formation in any of the groups. There was no difference between
group II and III.
4.3. Induced pluripotent stem cells
Due to the ethical issues associated with the use of human ESC,
there was a great need to ﬁnd alternate source of stem cells.
Takahashi et al. [30] made a breakthrough by generating induced
pluripotent stem cells (iPSC) from mouse and human ﬁbroblasts,
using retrovirus containing human pluripotency-related tran-
scription factors (i.e. Oct3/4, Sox2, Klf4, and c-Myc).
The generated iPSC expressed surface antigens speciﬁc to ESC,
including TRA-1-60, TRA-1-81, TRA-2-49/6E, NANOG Protein, SSEA-
3, and SSEA-4. Currently, further studies are being conducted on
iPSC as a promising substitute to ESC, and to test their safety and
efﬁcacy.
4.4. Epidermal neural crest cells
4.4.1. Introduction
Epidermal neural crest stem cells (EPI-NCSC) represent the
remnant of embryonic neural crest stem cells. Postnatally, they are
found in bulge of hair follicles. EPI-NCSC have been shown to ex-
press neuronal, GABAergic, and oligodendrocytes markers but lack
astrocytes or Schwann cells markers. These cells do not form tu-
mors or teratoma at the transplant site.
4.4.2. Isolation and culture
In the study of Hu et al. [14]; EPI-NCSC were used to repair SCI in
mouse. Wild type C57BL6/J and C57BL/6-TgN (ACTbEGFP)1Osb
mice, which expresses EGFP, were used for the experiment. 10e12
weeks mice were used to acquire bulge explant from whisker fol-
licles. After dissecting the whiskers, tungsten needles were used to
scrape the connective tissue from the follicle and rinsed to expose
the ring sinus and cavernous sinus. Longitudinal cut was made in
the capsule and then cut above and below the bulge to remove the
bulge out of capsule. Collagen-coated plates with culture media
containing 85% a-modiﬁedMEM,10% fetal calf serum, and 5% day11
chick embryo extract were used to grow bulge explants. Within
3e4 days, cells started to migrate from the bulge. Bulge was
removed from the media and the cells were trypsinized and
subcultured.
4.4.3. Transplantation
T8 laminectomy was performed. Moderate SCI in the midline
was induced with a modiﬁed Newton meter at a force of 12 centi-
Newtons for a duration of 3 s 0.8 ml of EPI-NCSC was injected on the
left side of spinal cord to both rostral and caudal margins, to bridge
the lesion. Injections were made for a duration of 4e5 min.
Approximately 1.4  105 ± 2.3  104 cells per mouse were injected.
4.4.4. Electrophysiological study
Spinal Evoked Potential (SpSEP) were recorded for 19 mice with
SCI and EPI-NCSC graft, 22 mice with SCI and saline injection, and 6
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do the recording, animals were anaesthetize and two Teﬂon wires
with 7-strands (0.0254 mm diameter with 3 mm deinsulation re-
gion) were placed subcutaneously, rostral to the injury at T4-level.
High input impedance module (2 TU) and 10 pF capacitance were
used to record from the electrodes. 23G needle was placed subcu-
taneously for stimulation, 3 cm caudal to the caudally placed
recording electrode, and to serve as anode. A 23G blunt needle was
placed in popliteal fossa to stimulate the tibial nerve. The tibial
nerve was stimulated at 3.5 Hz frequency for pulse duration of
500 ms and intensities of 1, 2, and 3 with a constant current
stimulator. Motor threshold ranged between 0.47 and 0.49mA in all
groups. Each leg and stimulation intensities were used for re-
cordings. The analysis of SpSEP was performed 4 month after
injury. Uninjured group showed SpSEP of 29.08 ± 7.3 mV in the right
hind leg and 29.9 ± 5.1 mV in the left hind leg. In the group with SCI
and saline injection, SpSEP readings were 6.39 ± 2.0 (right hind leg)
and 6.05 ± 2.1 (left hind leg) mV. In the groupwith SCI and EPI-NCSC
graft, the SpSEP readings were 12.86 ± 3.5 mV in the right hind leg
and 13.27 ± 3.1 in the left hind legs. This group showed 44.4% of
SpSEP spinal cord response compared to the uninjured mice.
To check the cutaneous sensitivity, Semmes-Weinstein touch
test was used. It consisted of varying thickness ﬁlaments with
weight ranging from 0.008 to 300 g. Middle of the pawwas pressed
with ﬁlament tip at a 90 angle for a duration of 1.5e2 s. Response
was recorded in form of clasping reﬂex. Gap of 2 min was used in
between the tests to avoid desensitization. In non-injuredmice, the
threshold response in the right hind leg was 7.3 ± 0.8 g and
7.7 ± 0.9 g in the left hind leg. In the group with SCI and saline
injection, the response was 141 ± 50.2 g in the right hind leg and
242.2 ± 29.9 in the left hind leg. In SCI group with EPI-NCSC graft,
the threshold response was 5.2 ± 0.5 in the right hind leg
(p ¼ 0.0001) and 5.2 ± 0.5 (p ¼ 0.0001) grams in the left hind leg,
which shows bilateral recovery of cutaneous sensitivity.
4.4.5. Histological analysis
To prove the differentiation of EPI-NCSC graft into myelinating
oligodendrocytes, immuno-electron microscopy was performed.
After anesthesia, the animals' spinal cord lesion site was exposed,
and 4% paraformaldehyde drops were placed at the level of injury
and on spinal cord. Ten minutes after this procedure, mice were
euthanized, and the spinal cord with injury site was removed and
incubated for 30 min in 4% PFA in 0.1 M phosphate buffer at a pH of
7.3. Fluorescence microscopy was performed to visualize EGFP
signal. The ﬂuorescent sections were cut into 200 mm sections and
froze in high pressure freezing apparatus and were placed in
ethanol, in 0.5% uranyl acetate, and then into Lowicryl K11M resins.
Ultrathin sections of the specimen were mounted on formvar-
coated grid. These sections were probed with anti-GFP polyclonal
rabbit serum. Goat anti-rabbit 10 nm gold probe was used to
visualize anti-GFP antibody. Retrograde tracing was performed to
check the connections between the grafted cells and spinal cord.
Alexa Fluor 680-conjugated dextran was used for tracing and its
retrograde transport suggested that neurites from the injured spi-
nal cord were able to traverse the scar. Also the EPI-NCSC derived
cell bodies and neuritis show a red ﬂuorescence. Green ﬂorescence
grafted cells with no red ﬂuorescence were also present.
4.5. Valproic acid and neural stem cell transplantation
4.5.1. Introduction
Valproic acid (VPA) is an anti-epileptic and mood stabilizing
drug used primarily for epilepsy and bipolar disorders. Recently,
VPA has been found to be a direct inhibitor of histone deacetylase
and resulted in hyperacetylation of histones in teratocarcinoma.VPA also suppress differentiation of astrocytes and oligodendro-
cytes, but, on the other hand, it acts as a neuronal differentiation
inducer.
4.5.2. Method
4.5.2.1. Isolation and culture. Abematsu et al. [1] have combined
Valproic acid with transplanted NSC to aid recovery in SCI. Three
different Tg mouse lines were used to produce NSC from embryonic
forebrains. GFP (GFP-Tg), GFP & LUC (GFP.LUC-Tg), and/or GFP, LUC
and diphtheria toxin receptor (TR6.GFP.LUC-Tg) were among the
factors expressed by these mouse cell lines. Expression of these
factors helps in the differentiation of host cells from NSC. Toxin
receptor-mediated conditional knock out procedure (TRECK) was
used for the ablation and visualization of the target cells. NSC stem
cells derived from E14.5 forebrains were used for transplantation.
E14.5 forebrains were derived frommice which were heterozygous
for GFP and LUC, TR6.GFP and LUC, and GFP. To obtain NSC, E14.5
forebrains were dissected and Hank's balanced salt solution (HBSS)
was used to triturate the forebrains, which were then plated on N2
DMEM/F-12 and 10 ng/ml bFGF containing poly-ornithine and
ﬁbronectin coated dishes for a duration of 4 days. The cells were
again placed on polyornithine and ﬁbronection coated dishes in NS-
Amedium supplementedwith 10 ngml of bFGF and EGF. Thewhole
process was repeated 5 to 10 times and the ﬁnal cells obtainedwere
used for transplantation. These NSC were positive for MAP2ab
(neurons), GFAP (astrocytes), and MBP (oligodendrocytes).
4.5.2.2. Transplantation. Fifteen week old male ICR mice (37e45 g)
were used for SCI model. T9 and partial T10 laminectomy was
performed. After exposing dura, the spinal cord was injured by an
impactor device using 90 kilodyne force. NSC were transplanted
into the injured spinal cord 7 days after the impact injury. Micro-
pipettes were used to inject 2 ml of NS with no growth factor and
supplemented with or without NSC in concentration of 0.5 106/ml
at 1 ml/min. Cyclosporine in a dose of 8 mg/kg was given to both
groups to suppress the immunity. Mice were also injected with VPA
in a dose of 150 mg/kg (group I), and saline (control group) for 7
days following transplantation of NSC.
4.5.3. Results
4.5.3.1. Behavioral assessment. BBB scale was used to evaluate
hindlimb movements for the duration of 14 weeks post SCI. Hin-
dlimb function in control group mice did not show much
improvement (BBB score of approximately 4), but the mice treated
with NSC and VPA showed signiﬁcant improvement (BBB score 9
to10). All the mouse groups transplanted with three different NSC
showed comparable data with no signiﬁcant difference. The re-
covery from injury reached its peak at 6 weeks post SCI and
remained sustained for duration of 3 months.
To check whether the functional recovery was due to host cor-
ticospinal tract axon (CST) extensions or due to extension of
neuronal processes from transplanted neuronal cells, biotinylated
dextran amine (BDA) was injected into the right and left motor
cortices (2 ml per cortex). BDA is an anterograde label, and only ﬁrst
grade neurons can be tagged with it. No CST axons were present in
the caudal site of SCI in control group and NSC and VPA-treated
group, which clearly indicates that CST re-extension was not the
cause of improvement. To see if transplanted NSC contributed to
the functional recovery, it was found that the transplanted cells in
the VPA and NSC treated groups migrated both dorsally and
ventrally and also extended their processes to the gray matter and
dorsal funiculus 5 weeks after transplantation.
The regeneration of disrupted circuitry connections was
conﬁrmed by injection of wheat germ agglutinin (WGA), which is a
tracer for neuronal pathway and can be transported trans-
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after the SCI, adenovirus with WGA expression was injected into
the motor cortex of the mice. In uninjured mice, WGA was traced
throughout the ventral horn of spinal cord in the form of intra-
cellular granules in neurons. In SCI group with no treatment, tracer
was absent caudally below the level of the injury. In SCI group
treated with NSC and VPA, WGA granules were found in the caudal
neurons and also in the transplanted neurons in and close to the
injury site, which conﬁrmed that the transplanted neurons recon-
struct the neuronal circuits. In SCI groups with only NSC trans-
plantation, WGAþ neurons were higher in number than the
untreated group but lower than the group with NSC and VPA
treatment.
4.5.3.2. Histological analysis. Immunohistochemical analysis of
transplant-derived neurons showed the expression of vesicular
glutamate transporter (VGLUT)-2 in 16.9% ± 2.3% neurons and
glutamic acid decarboxylase (GAD)-65 in 70.1% ± 1.8% neurons,
which are markers for glutamatergic and GABAergic neurons,
respectively, and shows that both excitatory and inhibitory neurons
were generated from the transplanted NSC. To conﬁrm if the
functional recovery was a result of neurons from the transplanted
cells, ablation was performed by diphtheria toxin. All the neurons
derived from TR6.GFP.LUC-NSC were ablated and the BBB score
from group with TR6.GFP.LUC-NSC and VPA decreased to the level
of score from untreated and VPA only-treated mice, which support
the hypothesis that the functional recovery was contributed to the
transplanted neurons and VPA administration. To see if both
endogenous and neurons derived from transplanted cells contrib-
uted to hindlimb functional recovery, neurons in the gray matter
were ablated 12 weeks after SCI by injecting NMDA (0.5 ml in a
concentration of 10 mM) at T9 vertebral level. NMDA is an axon
sparing excitotoxin. Bilateral injections were made in 5 GFP.LUC-
NSC with VPA treatment group, 3 TR6.GFP.LUC-NSC and VPA
group, and 3 untreated mice group. The NMDA injection did not
cause any change in hindlimb function of uninjured mice, but in
treatment groups the functional recovery was completely reversed,
which indicate that both endogenous neurons and neurons derived
from transplanted cells contributed to hindlimb functional
recovery.
4.5.3.3. Role of valproic acid. To conﬁrm the neuroprotective effect
of VPA, both cultured and transplanted neurons were treated with
VPA and Valpromide (VPM). VPM is a VPA amide analog which do
not inhibit histone deacetylase. VPA promoted both neuronal dif-
ferentiation and growth of neuritis from the transplanted NSC, but
inhibited the differentiation into astrocytes and oligodendrocytes.
VPM did not result in differentiation of neurons and acetylation of
histones, which clearly suggested that histone deacetylase inhibi-
tion is an important factor in the differentiation of transplanted
neurons. Similarly, the histone acetylation was greatly increased in
transplanted cells in injured spinal cord. With VPA treatment, the
transplanted cells were also differentiated into neurons rather than
glial cells at 1 week and 5 weeks after the SCI. At 5 weeks, therewas
enhancement of the number of cells positive for MAP2, which is a
late differentiation marker for neurons. On the contrary, VPM did
not show any differentiation of neurons or improvement of hin-
dlimb motor functions, which further strengthen the hypothesis
that inhibition of histone deacetylase is a major contributory factor
in neuronal differentiation.
4.6. Neural stem cell transplantation in chronic spinal cord injury
4.6.1. Method
Salazar et al. [25] transplanted human NSC (hNSC) in NOD-scidmice 30 days post SCI to detect functional recovery at an early
chronic SCI stage. NOD-scidmice is an immunodeﬁcient strain that
lacks complements, T-cell, and B-cell response, and does not ex-
press graft rejection. 16e20 weeks old fetal brain tissue was used to
isolate and culture hNSC. Fluorescence-activated cell sorting (FACS)
technique was used to produce single cell suspension.
4.6.1.1. Isolation and culture. The culture media contained FGF, EGF,
LIF, N-acetyl cysteine (NAC), neural survival factor-1, and ex-vivo
media with N2 supplement. To grow the human ﬁbroblast (hFbs)
from fetal liver, MDM in 10% FBS was used. 50,000 cells/ml con-
centrations were produced after washing and dissociation by
trypsinization. 8e10 weeks old female NOD-scid mice were used
for SCI model, and were divided into three groups: SCI group
transplanted with vehicle, SCI group with hNSC, and SCI group
transplanted with hFbs.
4.6.1.2. Transplantation. After T9 laminectomy, contusion injury
was inﬂicted using Inﬁnite Horizon (IH) impactor with a force of
50 kilodyne. Thirty days post SCI, transplantation of hNSC and hFbs
was performed. Four injections, 250 nl each, in a concentration
containing 75,000 cells/ml of hNSC or 50,000 cells/ml of hFbs in 50%
Hank's balanced salt solution and 50% ex-vivo medium were per-
formed bilaterally from the midline, rostral and caudal to the
impact site. The control group received injection of buffer solution
only.
4.6.2. Results
4.6.2.1. Behavioral assessment. BMS was used to assess locomotor
recovery 2 days after the SCI, followedweekly for 4 weeks, and then
weekly after the transplantation till sacriﬁce. The animals were also
tested for motor function using BMS scale before inclusion into the
study and the animals with motor deﬁcits were excluded. The mice
group with hNSC transplantation showed better locomotor recov-
ery as compared to hFbs group and vehicle group. The BMS score at
16weeks was 6.4± 0.4 for hNSC group, 5.6 ± 0.6 for hFbs group, and
4.8 ± 0.5 for vehicle group. Coordination between the forelimb and
hindlimb was also compared between the groups. hNSC trans-
planted group had 64% of mice with improved coordination. 44% of
hFbs group and 20% of vehicle group showed improved coordina-
tion. Prior to sacriﬁce, at 16 weeks post SCI, catwalk gait analysis
was performed to analyze the swing speed. 1.21 m/s ± 0.06 swing
speed was shown by hNSC group as compared to 1.05 m/s ± 0.06 by
vehicle group, but hFbs group showed swing speed of 1.13 m/
s ± 0.04 and was signiﬁcantly different from other groups. Allo-
dynia in the hindlimb was tested at15 weeks after the trans-
plantation. Von Frey Hair testing was performed to measure the
threshold for withdrawal response with higher force ﬁlaments.
Recent studies have shown that the astrocytes derived from
transplanted NSC have direct correlation with allodynia. The group
with hNSC transplant showed a threshold of 6.4 g ± 1.4 as
compared to hFbs with 6.0 g ± 0.5 and vehicle group with
6.0 g± 1.0. This shows no signiﬁcant difference between the groups,
and hence, the group with hNSC transplantation did not have
altered threshold response to mechanical allodynia.
4.6.2.2. Histological analysis. The survival and migration of the
transplanted cells into the host spinal cord was tested at 16 weeks
post transplantation. Optical fractionators probe was utilized to
quantify the surviving cells. The group with hNSC transplant
showed 215,711 ± 48,978 hNSC on stereological estimate, which is a
three times increase from the transplant number of 75,000 cells.
The group with hFbs transplant showed 11,701 ± 3070 hFbs, a 4
times decrease in cell count from transplantation number of
50,000 cells. T6-T12 segment of spinal cord (8mm rostral and 5mm
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hFbs migrated into the spinal cord. HNSC migrated up to 8 mm
rostral and 5 mm caudal to the injury epicenter as compared to
hFbs, which migrated only 2 mm rostral and 2 mm caudally. On
quantiﬁcation of surviving cells at the distal rostral segment, there
were 384 hNSC at 8 mm and 697 at 7 mm. At the distal caudal
segment there were 1019 hNSC at 4 mm and 244 hNSC at 5 mm.
SC121 and Ki67 double labeling of the human cells was performed
to see the active cell proliferation capability. Sc121 and Nestin
double labeling was also used to see if the cells can retain imma-
turity at 16 weeks post transplantation. There was a limited pro-
liferation of hNSC, as 2.9% ± 1.06 SC121þ human cells were double-
labeled for Ki67 but 31.1% ± 3.23 of cells were double-labeled with
SC121 and Nestin, which conﬁrmed their immaturity. Engrafted
human cell were also analyzed for Olig2 (immature oligodendro-
cytes), APC-CC1 (mature oligodendrocytes), bIII-Tubulin (neurons),
and GFAP (astrocytes) markers. 34.4% ± 6.38 cells expressed Olig2
and 13.8%± 1.0 human cells expressed AAP-CCImarker. bIII-Tubulin
and GFAP were expressed by 38.1% ± 0.85 and 8.0% ± 1.0 of the
SC121þ cells, respectively. Approximately 40.78% of the engrafted
cells differentiated into oligodendrocytes (mature and immature
lineage). Oligodendrocytes differentiation was primarily in white
matter and bIII-Tubulin for neurons was mainly in gray matter. The
integration of hNSC with the host was conﬁrmed by confocal and
double immunoﬂuorescence for SC121 and contactin-associated
protein (CASPR) which shows co-localization of host myelinated
axons with CASPR in paranodal protein in white matter, conﬁrming
the host and hNSC integration.
5. Conclusion
Mice represent an attractive model for SCI as they are cost
effective and can be easily genetically modiﬁed. Different mecha-
nisms have been developed to induce SCI, but yet no mechanism
was deemed superior. These models have also been used for stem
cells therapy trials. Despite differences from human response, an-
imal models, and especially mouse, provides an insight into effec-
tiveness and possible complications of cellular isolation, expansion
and transplantation.
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